149 related articles for article (PubMed ID: 15074594)
1. Topical delivery of different acyclovir palmitate liposome formulations through rat skin in vitro.
Liu H; Pan WS; Tang R; Luo SD
Pharmazie; 2004 Mar; 59(3):203-6. PubMed ID: 15074594
[TBL] [Abstract][Full Text] [Related]
2. Comparison of liposome-encapsulated acyclovir with acyclovir ointment: ocular pharmacokinetics in rabbits.
Chetoni P; Rossi S; Burgalassi S; Monti D; Mariotti S; Saettone MF
J Ocul Pharmacol Ther; 2004 Apr; 20(2):169-77. PubMed ID: 15117573
[TBL] [Abstract][Full Text] [Related]
3. Enhanced transdermal delivery of acyclovir sodium via elastic liposomes.
Jain SK; Gupta Y; Jain A; Rai K
Drug Deliv; 2008; 15(3):141-7. PubMed ID: 18379926
[TBL] [Abstract][Full Text] [Related]
4. Assessment of correlation between skin target site free drug concentration and the in vivo topical antiviral efficacy in hairless mice for (E)-5-(2-bromovinyl)-2'-deoxyuridine and acyclovir formulations.
Afouna MI; Mehta SC; Ghanem AH; Higuchi WI; Kern ER; De Clercq E; El-Shattawy HH
J Pharm Sci; 1998 Aug; 87(8):917-21. PubMed ID: 9687333
[TBL] [Abstract][Full Text] [Related]
5. Improved permeability of acyclovir: optimization of mucoadhesive liposomes using the phospholipid vesicle-based permeation assay.
Naderkhani E; Erber A; Škalko-Basnet N; Flaten GE
J Pharm Sci; 2014 Feb; 103(2):661-8. PubMed ID: 24395733
[TBL] [Abstract][Full Text] [Related]
6. Failure of topical acyclovir in ointment to penetrate human skin.
Freeman DJ; Sheth NV; Spruance SL
Antimicrob Agents Chemother; 1986 May; 29(5):730-2. PubMed ID: 3729337
[TBL] [Abstract][Full Text] [Related]
7. Topical iontophoresis of valaciclovir hydrochloride improves cutaneous aciclovir delivery.
Abla N; Naik A; Guy RH; Kalia YN
Pharm Res; 2006 Aug; 23(8):1842-9. PubMed ID: 16850271
[TBL] [Abstract][Full Text] [Related]
8. In vivo quantification of acyclovir exposure in the dermis following iontophoresis of semisolid formulations.
Shukla C; Friden P; Juluru R; Stagni G
J Pharm Sci; 2009 Mar; 98(3):917-25. PubMed ID: 18623192
[TBL] [Abstract][Full Text] [Related]
9. Synergistic penetration of ethosomes and lipophilic prodrug on the transdermal delivery of acyclovir.
Zhou Y; Wei YH; Zhang GQ; Wu XA
Arch Pharm Res; 2010 Apr; 33(4):567-74. PubMed ID: 20422366
[TBL] [Abstract][Full Text] [Related]
10. Acyclovir-containing liposomes for potential ocular delivery. Corneal penetration and absorption.
Law SL; Huang KJ; Chiang CH
J Control Release; 2000 Jan; 63(1-2):135-40. PubMed ID: 10640587
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of acyclovir cream and gel formulations for transdermal iontophoretic delivery.
Siddoju S; Sachdeva V; Friden PM; Banga AK
Ther Deliv; 2012 Mar; 3(3):327-38. PubMed ID: 22833993
[TBL] [Abstract][Full Text] [Related]
12. Cocrystallization and amorphization induced by drug-excipient interaction improves the physical properties of acyclovir.
Masuda T; Yoshihashi Y; Yonemochi E; Fujii K; Uekusa H; Terada K
Int J Pharm; 2012 Jan; 422(1-2):160-9. PubMed ID: 22079714
[TBL] [Abstract][Full Text] [Related]
13. Influence of drug loading and type of ointment base on the in vitro performance of acyclovir ophthalmic ointment.
Al-Ghabeish M; Xu X; Krishnaiah YS; Rahman Z; Yang Y; Khan MA
Int J Pharm; 2015 Nov; 495(2):783-91. PubMed ID: 26343911
[TBL] [Abstract][Full Text] [Related]
14. Topical application of acyclovir-loaded microparticles: quantification of the drug in porcine skin layers.
de Jalón EG; Blanco-Príeto MJ; Ygartua P; Santoyo S
J Control Release; 2001 Jul; 75(1-2):191-7. PubMed ID: 11451509
[TBL] [Abstract][Full Text] [Related]
15. Topical delivery of acyclovir and ketoconazole.
Jacobs GA; Gerber M; Malan MM; du Preez JL; Fox LT; du Plessis J
Drug Deliv; 2016; 23(2):631-41. PubMed ID: 25005585
[TBL] [Abstract][Full Text] [Related]
16. In vitro percutaneous penetration of acyclovir from solvent systems and Carbopol 971-P hydrogels: influence of propylene glycol.
Díez-Sales O; Garrigues TM; Herráez JV; Belda R; Martín-Villodre A; Herráez M
J Pharm Sci; 2005 May; 94(5):1039-47. PubMed ID: 15793815
[TBL] [Abstract][Full Text] [Related]
17. Fabrication of acyclovir-loaded flexible membrane vesicles (FMVs): evidence of preclinical efficacy of antiviral activity in murine model of cutaneous HSV-1 infection.
Sharma G; Thakur K; Setia A; Amarji B; Singh MP; Raza K; Katare OP
Drug Deliv Transl Res; 2017 Oct; 7(5):683-694. PubMed ID: 28801835
[TBL] [Abstract][Full Text] [Related]
18. [Effects of liposomes formulation and preparation method on the stability of acyclovir palmitate liposomes].
Liu H; Tang R; He XX; Zhang Y
Yao Xue Xue Bao; 2002 Jul; 37(7):563-6. PubMed ID: 12914330
[TBL] [Abstract][Full Text] [Related]
19. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability.
Padamwar MN; Pokharkar VB
Int J Pharm; 2006 Aug; 320(1-2):37-44. PubMed ID: 16707237
[TBL] [Abstract][Full Text] [Related]
20. Influence of the treatment protocol upon the in vivo efficacy of cidofovir (HPMPC) and of acyclovir (ACV) formulations in topical treatment of cutaneous HSV-1 infection in hairless mice.
Afouna MI; Mehta SC; Ghanem AH; Higuchi WI; Kern ER; DeClercq E; El-Shattawy HH
J Pharm Sci; 1999 May; 88(5):530-4. PubMed ID: 10229644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]